Teclistamab Uses, Dosage, Side Effects and more
Teclistamab is under investigation in clinical trial NCT04557098 (A Study of Teclistamab, in Participants With Relapsed or Refractory Multiple Myeloma).
| Trade Name | Teclistamab |
| Generic | Teclistamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
